Molecular Communications
Introduction

More than 250 pleckstrin homology (PH) domains
The recent first draft of the human genome have been identified in the human proteome. All sequence [l] showed that pleckstrin homology PH domains studied to date appear to bind (PH) domains are the eleventh most common phosphoinositides, most binding only weakly and domain in humans, appearing in some 252 comnon-specifically. Members of a small subclass of ponents of the deduced human proteome. PH PH domains show both high affinity and specificity domains are small b-sandwich protein modules of for particular phosphoinositides, and recent structural studies have provided detailed views of these specific interactions. We discuss the architecture of the specific phosphoinositide-binding sites of PH domains, and how selectivity can be modulated by sequence changes.
approximately 120 amino acids that occur once or, more rarely, several times, in a protein sequence [ 2 4 ] . Their name is derived from pleckstrin [5], the major protein kinase C substrate in platelets, in which the module was first seen. In 1993, three groups noted that many proteins involved in cellular signalling, cytoskeletal organization, membrane trafficking and/or phospholipid modification contain similar modules [6-81. Nearly all PH domain-containing proteins require membrane association for some aspect of their function. Pairwise amino acid sequence identities between individual PH domains are generally poor, often lying in the range 10-30%, and PH domain identification in databases requires searching with sequence profiles [9-121. Lists of PH domains thus identified can be viewed conveniently on the world-wide web at http://SMART. embl-heidelberg.de and http://www.ebi.ac.uk/ interpro.
Most, if not all, PH domains bind to phosphoinositides present in cell membranes [24, 13] , although they do so with quite different degrees of specificity and affinity [14-161. In a few cases (perhaps 10 yo), phosphoinositide binding is strong and highly specific. Studies using green fluorescent protein (GFP) fusions have shown that phosphoinositide binding by these PH domains is sufficient for their independent, signal-regulated targeting to cell membranes [17-211. X-ray crystallographic studies have also provided a detailed structural understanding of high-affinity, specific phosphoinositide binding, which allows the binding characteristics of some PH domains to be predicted accurately [22-251. The vast majority of PH domains show only weak, quite non-specific, binding to phosphoinositides and other anionic phospholipids [2, 14, 16] . In only few cases has this binding been demonstrated to have functional importance. Where a role has been shown, the PH domain either participates in membrane association through co-operation with other domains in the same protein [26-281 or requires oligomerization of its host protein in order to increase membranebinding avidity [29-321.
PH domain structure
NMR or X-ray crystal structures have been determined for 12 different PH domains [23] [24] [25] [26] 33401 . All share the same core structure, despite the fact that pairwise sequence identities among the domains range from just 7 % to a maximum of only ~2 5 % [38] . The PH domain core, also seen in several other unrelated protein domains [2, 41] , is a seven-stranded /%sandwich of two nearly orthogonal /3-sheets that contain fourand three-strands respectively (Figure 1) . A characteristic C-terminal a-helix closes off one open corner of the B-sandwich (top in Figure l) , whereas three interstrand loops (the most variable in PH domains) close off the opposite open corner (bottom in Figure 1 ). As shown in Figure 1 , these three variable loops abut the membrane surface when a PH domain binds to a phosphoinositide embedded in a lipid bilayer. With the exception of the recently determined Unc89 PH domain structure [40] , all PH domains of known structure are strongly electrostatically polarized. Their positively charged face projects towards the membrane surface in Figure 1 . Delocalized electrostatic attraction between this positively charged face and the negatively charged membrane surface is likely to contribute substantially to membrane targeting by PH domains.
Specific binding of PH domains to phosphoinositides is dictated by precise headgroup recognition
The first suggestion that PH domains bind to phosphoinositides came from the finding [13] that the N-terminal PH domain from pleckstrin binds weakly ( K , x 30 pM) to PtdIns(4,5)P2. Several groups [4244] later demonstrated that the PH domain from the N-terminus of phospholipase C-6, ) binds strongly and stereospecifically to both PtdIns(4,5)P2 and its isolated headgroup Ins( 1 ,4,5)P3. Calorimetric studies showed that the PLC-8, PH domain (PLCG-PH) actually binds 10-fold more strongly to Ins(1,4,5)P3 ( K , = 210 nM) than it does to PtdIns(4,5)P2 in vesicles under the same conditions (K,, = 1.7 pM) [42] . This difference probably arises because the PtdIns(4,5)P2 headgroup is sterically restricted at the membrane surface, and is less freely accessible than Ins( 1 ,4,5)P3 molecules that are free in solution. Binding of Ins(1,4,5)P3 to the PLC-6, PH domain is highly specific : addition, removal or rearrangement of any phosphate groups reduces binding affinity by at least 1 5-fold [42] . The 1.9 A (0.19 nm)-resolution X-ray crystal structure of the complex formed between PLCG-PH and Ins( 1 ,4,5)P3 [22] provided a structural explanation for this specificity. This structure also demonstrated how the PH domain could bind the lipid headgroup at the membrane surface without any obvious requirement for membrane penetration (see Figure 1) .
Subsequent studies demonstrated that a number of PH domains that bind PtdIns(4,5)P2 only weakly nonetheless bind very strongly to PtdIns(3,4,5)P3, the major product of agonistregulated phosphoinositide 3-kinases (PI 3-kinases). PtdIns(3,4,5)P3 is virtually undetectable in quiescent cells, but its levels rise rapidly to an estimated local concentration of around 150 p M [45] following stimulation of cells with a variety of agonists. PtdIns(3,4,5)P3 is thus a 'lipid second messenger ', generated by regulated 3-phosphorylation of PtdIns(4,S)P2. The PH domains from protein kinase B (PKB) [46, 47] , Bruton's tyrosine kinase (Btk) [ 15, 48, 49] and the general receptor for phosphoinositides-1 (Grpl) [SO] all bind specifically to PtdIns(3,4,5)P3. These PH domains select PtdIns(3,4,5)P3 over PtdIns(4,5)P2 by more than 100-fold {estimated local concentrations of PtdIns(4,5)P2 range from 3 to 5 m M
[45]}. Using G F P fusions, each of these P H domains has been shown to remain cytosolic in quiescent cells, but to be recruited rapidly to the plasma membrane when cells are treated with growth factors or other agonists [17-211. Membrane recruitment of these PH domains is prevented by treatment with wortmannin, an inhibitor of PI 3-kinases [17-211. P H domains that become targeted to the plasma membrane upon PI 3-kinase activation do so by binding strongly and specifically to the PtdIns(3,4,5)P3 headgroup, Ins(1,3,4,5)P4 [14, 23, 48, 51] . For example, the P H domains from G r p l and Btk bind to Ins(1 ,3,4,5)P4
with Kd values of 27 nM [14] and 4 0 n M [48] respectively. Indeed, all P H domains studied to date that bind specifically to a given phosphoinositide do so through headgroup recognition [2] , and bind at least as strongly to the isolated headgroup as they do to intact phospholipid. Interestingly, there is one case in which headgroup recognition appears to be more specific than phosphoinositide binding. T h e P H domain from a Ras GTPase-activating protein, GAP1 ''IBP, binds Ins(1,3,4,5)P4 with very high affinity ( K , = 31 nM) and specificity [52] , yet is constitutively membrane-associated [binding also to PtdIns(4,5)P2]. It has been suggested that the P H domain of this protein acts as an Ins(1,3,4,5)P4 receptor present in a membrane-associated protein [531.
Sequence predictors of high-affinity phosphoinositide binding Isakoff et al. [54] tested the ability of a number of P H domains to bind with high affinity to PtdIns(4,5)P2 and PtdIns(3,4,5)P3 [or PtdIns(3,4)P2] using a novel assay in yeast. Yeast with a temperature-sensitive mutation in cdc25 fail to activate Ras (and therefore to grow) at the 
Hypothetical view of how the PH domain from DAPPI [55] binds to a
restrictive temperature. This defect can be overcome by targeting a constitutively active form of Ras (Ras Gln'lLeu) to the plasma membrane. P H domains that bind strongly to PtdIns(4,5)P2 or other yeast plasma membrane components can target Ras Gln'lLeu to the membrane when fused to the Ras mutant, allowing rescue of temperaturesensitive cdc2Sts yeast. When Ras Gln'lLeu is fused to a P H domain that binds weakly to PtdIns(4,5)P2, but strongly to PtdIns(3,4,5)P3 and/or PtdIns(3,4)P2, the cdc2S" mutant is only rescued when a constitutively active form of PI 3-kinase is also expressed in the yeast. Isakoff et al.
[54] defined a sequence motif that is present in all P H domains capable of high-affinity binding to PI 3-kinase products defined by this assay. This motif has proven to be a strong predictor of PI 3-kinase product binding by previously uncharacterized P H domains [54] . T h e motif is centred on the loop that connects strands /?1 and 82 of the PH domain : the loop that is most membrane-proximal in the P H domain depicted in Figure 1 , and closely approaches the bound phosphoinositide. T h e sequence pattern defined by this motif may be written :
where CP denotes an amino acid with a hydrophobic side chain, x represents any amino acid, * represents any number of amino acids, and the subscripts refer solely to the position within the motif (for discussion purposes).
Structural basis for high-affinity binding of PH domains to PI 3-kinase products
Every P H domain that binds with high affinity and specificity to PI 3-kinase products contains the sequence motif described above. T h e importance of each residue within this motif has recently been revealed in three published X-ray crystal structures of PH domains bound to Ins (1,3, Figure 2 shows a close-up view of Ins(1,3,4,5)P4 bound to the G r p l P H domain [24] , in which the function of side chains required by the motif can be described as follows: 'a' is the hydrophobic side chain that occurs at the start of the motif (not shown in Figure 2) , and projects from strand B1 into the hydrophobic core of the P H domain, where it plays a structural role. 'K,' is the first lysine in the motif, and corresponds to Lys273 in Figure 2 (as shown in the centre of the Figure) . This residue is at the very end of strand Pl in the P H domain. T h e side chain of Lys273 plays a critical role in ligand binding by the P H domain, with its amino group forming hydrogen bonds with both the 3-and 4-phosphates of Ins(1,3,4,5)P4. T h e side chain of residue x2 (274 in Grpl-PH) which faces away from the binding site does not affect binding. T h e identity of this amino acid is unimportant. ' [G/A/S/P] ' denotes a point where the protein backbone at position 275 comes very close to the 5-phosphate of Ins(1 ,3,4,5)P4, and the side chain of residue 275 points directly towards this phosphate group. Thus a large side chain at position 275 would clash sterically with the 5-phosphate, explaining why a glycine, alanine, serine or proline is always found at this position (Gly"' in G r p l -P H ; shaded grey in on the same side of strandP2 as LysZE2 in Grpl-PH projects the side chain of Arg284, which corresponds to R,, in the motif of Isakoff et al. Arg284 is a highly critical residue in Grpl-PH, and forms two hydrogen bonds with the 3-phosphate group of Ins(1,3,4,5)P,. R,, corresponds to ArgZ8 in Btk, at which mutations that cause X-linked agammaglobulinemia were first identified in this protein [58, 59] . Mutation of Arg2' in Btk-PH abolishes PtdIns(3,4,5)P3 and Ins(1 ,3,4,5)P4 binding [48, 49] , leading to a loss of function. An equivalent mutation in the PKB-PH domain (at Arg2') is similarly disruptive for both PtdIns(3,4,5)P3 binding and response to PI 3-kinase activation [46, 47] . In fact, mutation of Riv, when identified in any P H domain, has been used in a wide variety of cases to abolish presumed or demonstrated phosphoinositide and/or inositol phosphate binding.
' [F/L] ' is the final residue in the motif (Phe2" in Grpl-PH), and has a hydrophobic side chain (not shown in Figure 2 ) that projects into the hydrophobic core of the P H domain. In association with at the beginning of the motif, this is likely to 'anchor' the p1/82 loop.
Some of the other interactions depicted in Figure 2 are highly conserved in all P H domains that bind PI 3-kinase products. Tyr295, which forms a hydrogen bond with the 4-phosphate of Ins( 1 ,3,4,5)P4, has an equivalent in the Btk-PH and DAPPl-PH domain structures, and is conserved in sequence alignments of PI 3-kinase product-binding P H domains. Lietzke et al. [25] have included this tyrosine in a revised motif. An arginine or lysine aligns with Arg305 of Grpl-PH when sequences of P H domains that bind PI 3-kinase products are compared. T h e equivalent residue in Btk-PH (a lysine) interacts with the 3-phosphate of Ins(1,3,4,5)P4. In contrast, the side chain of the analogous arginine in DAPPl-PH (ArgZo5) projects upwards (with respect to that shown in Figure 2 ), to form a hydrogen bond with the 4-phosphate, rather than the 3-phosphate, of Ins(1 ,3,4,5)P4. T h e remaining side chains that surround the 5-phosphate in Figure 2 ( L Y s~~~, Asn354 and His355) are specific to Grpl-PH.
Distinct specificities of PH domains for PI 3-kinase products
Among the P H domains that contain the sequence motif described above, some bind only to PtdIns(3,4,5)P3, whereas others bind equivalently both PtdIns(3,4,5)P3 and PtdIns(3,4)Pz. T h e G r p l -and Btk-PH domains are examples of PtdIns(3,4,5)P3-specific P H domains, whereas the PKB-and DAPPl-PH domains are examples of those that do not distinguish PtdIns(3,4)Pz from PtdIns( 3,4,5)P, [ 14,s 1,55361. PtdIns(3,4)PZ is thought to be produced largely by 5-dephosphorylation of PtdIns(3,4,5)P3 [45] (although other pathways have been reported [60, 61] ). Consistent with this, whereas PtdIns(3,4,5)P3 accumulation in activated platelets is immediate and transient (complete within 2 min), PtdIns(3,4)Pz accumulation is delayed and more sustained [47] . Residues that form hydrogen bonds with the bound Ins(1,3,4,5)P4 are marked. Of these residues, those that form part of the motif described by lsakoff et al.
[54] as a predictor for PI 3-kinase product-binding PH domains are circled. The /3l/pZ loop is marked.
loop
A PH domain that recognizes only PtdIns(3,4,5)P3 will therefore be recruited more transiently to the plasma membrane than one capable of binding both PtdIns(3,4)P2 and PtdIns(3,4,5)P3. T o understand the basis for this specificity, we recently compared the crystal structures of DAPPl -PH and Grpl-PH bound to Ins(1,3,4,5)P4 [24] . As shown in Figure 3 , when Ins(1,3,4,5)P4 is bound to Grpl-PH (Kd = 27 nM), the 3-, 4-, and 5-phosphates (all required for strong binding) are accommodated in deep pockets, and all are inaccessible to solvent. Each of these phosphate groups is hydrogen-bonded to at least two of the Grpl-PH side chains. In contrast, when Ins(l,3,4,5)P, binds to DAPPl-PH ( K , = 43 nM), the 5-phosphate (not required for binding) does not lie in a defined pocket, and remains largely solvent-accessible. The side chains in Grpl-PH that form hydrogen bonds with the 5-phosphate in Figure 2 are absent in the DAPP1-PH domain, including Arg277 of Grpl-PH ([K/ R], in the motif), which is replaced by leucine in DAPP1-PH. As a result of these (and other) differences, the presence of the 5-phosphate is not important for recognition of PtdIns(3,4,5)P3 by the DAPP1 -PH domain. Thus, whereas Grpl-PH binds Ins( 1 ,3,4,5)P4 nearly 100-fold more strongly than Ins(1 ,3,4)P3, the preference of DAPP1-PH for Ins (1, 3, 4, 5)P, over Ins(1, 3, 4) P3 is just 3-fold 1241.
PH domains that do not bind Ptdlns(3,4,5)P, or Ptdlns(3,4)P2
Of the 252 known human PH domains, there are perhaps just 20 that bind strongly to PtdIns(3,4,5)P3 and/or PtdIns(3,4)P2 using the binding site described here. The remaining 230 or so human PH domains, and all 35 PH domains from Saccharomyces cerevisiae (where these phosphoinositides are not produced), lack the sequence motif described above. The motif is either completely unrecognizable in these PH domains, or is conserved only in part. Where some elements of the motif remain, one might expect formation of a binding site that is similar in nature, but different in detail. In these cases, distinct specificities for phosphoinositides (or other lipids) might be anticipated. That this can be true is illustrated well with the PLC-8, PH domain, in which the entire motif outlined above is conserved, except that there is a lysine at the (G/A/S/P) position, and there is no basic residue in the 81 /82 loop. As discussed above, PLCG-PH binds strongly ( K , = 210 nM) to Ins(1,4,5)P3, with an Residues that interact with Ins( 1,3,4,5)P, are coloured light grey. As described in the text, whereas the 3-and 4-phosphates are well buried in both complexes, the 5-phosphate is only substantially buried in the Ins( I ,3,4,5)P4-Grp I -PH domain complex. In cases where the sequence differed from the motif at just one position, specific phosphoinositide binding could be observed, but the preferred phosphoinositide was something other than PtdIns(3,4,5)P3. One PH domain (from phosphatidylinositol 4-phosphate adaptor protein-1, or FAPP1) with a glutamine at the [K/R],, position was found to be specific for PtdIns4P. Another (from phosphatidylinositol-3-phosphatebinding PH-domain protein-1, or PEPPl), in which an aspartate occupies the (G/A/S/P) position, was specific for PtdIns3P. Still another (from centaurin-p2), in which an asparagine is found at the [K/R],, position, appeared to bind PtdIns(3,5)P2 most strongly. We anticipate that the binding sites of these PH domains will broadly resemble that shown in Figure 2 for Grpl-PH, but that the precise details, including the orientation of the inositol phosphate or phosphoinositide ligand [2, 22, 23] , will differ.
DAPP1-PH
PH domains that bind only weakly and promiscuously to phosphoinositides
Even allowing for significant variation, fewer than 20% of all known PH domains contain sequence patterns reminiscent of the specific inositol phosphate/phosphoinositide binding sites described here. In the S. cerevisiae genome, for example, where 35 distinct PH domains can be discerned, only four or five can be clearly argued to have a binding site related to those outlined here. This begs the question as to the role of the remaining 80 to 90% of the members of this very common domain family. As pointed out above, even those PH domains that do not appear to have specific binding sites can bind to phosphoinositides [ 1 4 161. However, they do so with low affinity and poor specificity. This weak and promiscuous binding, observed in most cases only in vitro, may not be physiologically important for all PH domains. That it is important in some cases can be argued from results obtained with the P-adrenergic 383 receptor kinase [26] and with dynamin [29-321. In these cases, membrane binding appears to require the co-operation of multiple weak binding sites. Such participation in multidomain targeting events might be a general function for PH domains from this large class, although this has yet to be demonstrated in many cases and other functions or targets should not be ruled out. 
